about
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?Transcriptome sequencing and identification of cold tolerance genes in hardy Corylus species (C. heterophylla Fisch) floral budsTranscriptome analyses of a Chinese hazelnut species Corylus mandshuricaEphrinB1: novel microtubule associated protein whose expression affects taxane sensitivityNanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patients.Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study.Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancerBreast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib.Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation.Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?Targeting the cell cycle in breast cancer: towards the next phaseAcupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
P2860
Q26745420-0F4B9CB3-B4F6-4EA5-83D0-866EAFDB56B1Q34277379-29F1AED9-BFB9-4CE9-A478-2438B4F97AC3Q35008029-92332C3B-526A-42B0-B6E8-4DFE04FF758EQ35176185-A1E159EF-7425-4CC2-B190-253BA05F16B2Q35507680-47021FF2-717F-408A-A690-3E6238279893Q36187896-AD719813-E0E0-4CCD-A133-5FDC57995E44Q36326026-7E1BE6FC-7091-4151-B7D8-4299C49AD54EQ36678462-E1152C03-7195-4AC9-853D-74F782FBDDCCQ36687107-01ED60B2-79FF-4576-8E35-3D84A8A4F159Q37205970-D6DC392C-D419-482D-A4FF-7B224A9A54CCQ37504284-88CFB343-BC91-4B40-B5ED-2EE3E99D78CBQ55555000-4B1A5471-6857-4FE5-909C-88A1B1C0C4F8Q57115037-21553E70-960A-44FB-B9DD-D029975929C3Q58699231-3D6C7697-E660-4625-B36D-2EC3B0E954B2
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Taxanes for the treatment of metastatic breast cancer.
@ast
Taxanes for the treatment of metastatic breast cancer.
@en
type
label
Taxanes for the treatment of metastatic breast cancer.
@ast
Taxanes for the treatment of metastatic breast cancer.
@en
prefLabel
Taxanes for the treatment of metastatic breast cancer.
@ast
Taxanes for the treatment of metastatic breast cancer.
@en
P2860
P356
P1476
Taxanes for the treatment of metastatic breast cancer.
@en
P2093
W J Gradishar
P2860
P304
P356
10.4137/BCBCR.S8205
P577
2012-10-25T00:00:00Z